What are the features of HICKY's device?

It is a minimally invasive neurostimulation device that combines a stent-type structure with wireless power transfer, eliminating the need for a subcutaneous generator.

What is Central Sleep Apnea (CSA)?

A condition where breathing stops during sleep, which is a serious issue linked to worsening heart failure and increased mortality risk.

What is the purpose of this funding?

To accelerate device miniaturization, advance preclinical and clinical trials, handle regulatory affairs, and build a global clinical collaboration network.

AI News NQ Analysis

HICKY Secures Funding from Tokyo Wellness Impact Fund and CJS Fund No. 2 to Develop Innovative Treatment for Central Sleep Apnea in Heart Failure Patients

NQ Score 50/100

AI Summary (NQ-processed)

HICKY, a developer of innovative treatment devices for central sleep apnea, has raised funds to accelerate the development of its stent-type, wireless-powered neurostimulation device.

AI analysis data is not yet available.

Frequently Asked Questions

Q: What are the features of HICKY's device?: A: It is a minimally invasive neurostimulation device that combines a stent-type structure with wireless power transfer, eliminating the need for a subcutaneous generator.
Q: What is Central Sleep Apnea (CSA)?: A: A condition where breathing stops during sleep, which is a serious issue linked to worsening heart failure and increased mortality risk.
Q: What is the purpose of this funding?: A: To accelerate device miniaturization, advance preclinical and clinical trials, handle regulatory affairs, and build a global clinical collaboration network.